Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Application
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Mertansine-13C-d3 is intended for use as an internal standard for the quantification of mertansine (Item No. 22483) by GC- or LC-MS. Mertansine is a synthetic maytansinoid antimitotic agent.1,2 It is cytotoxic to KB epidermoid carcinoma and SK-BR-3 breast cancer cells (IC50 = 1.1 nM for both).1 Mertansine has commonly been used as a payload in antibody-drug conjugates (ADCs) that selectively target cancer cells in vitro and in animal models.3,4,5 Formulations containing mertansine conjugated to ado-trastuzumab have been used in the treatment of HER2+ breast cancer.
WARNING This product is not for human or veterinary use.
1. Semisynthetic maytansine analogues for the targeted treatment of cancer. J. Med. Chem. 49(14), 4392-4408 (2006).
2. Antibody-
3. Lorvotuzumab mertansine: Antibody-
4. A novel dual-
5. A novel antibody-